Citation: Li Xiang, Jingchun Shi, Zifan Zhu, Yi Ru, Lin Peng, Wei Wang, Hongzhi Zhao, Runhui Liu, Yujie Pu, Lei He, Li Wang, Zongwei Cai. Lipidomics study of the regulatory effects of PPARδ agonist GW501516 in plasma of db/db diabetic mice[J]. Chinese Chemical Letters, ;2025, 36(11): 110910. doi: 10.1016/j.cclet.2025.110910 shu

Lipidomics study of the regulatory effects of PPARδ agonist GW501516 in plasma of db/db diabetic mice

Li Xiang ^{a, 1} ,
Jingchun Shi ^{a, 1} ,
Zifan Zhu ^{a, 1} ,
Yi Ru ^a ,
Lin Peng ^a ,
Wei Wang ^a ,
Hongzhi Zhao ^c ,
Runhui Liu ^d ,
Yujie Pu ^b ,
Lei He ^b ,
Li Wang ^{b, *,} ,
Zongwei Cai ^{a, *,}

a.
State Key Laboratory of Environmental and Biological Analysis and Department of Chemistry, Hong Kong Baptist University, Hong Kong SAR 999077, China
b.
Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR 999077, China
c.
Ministry of Education Key Laboratory of Pollution Processes and Environmental Criteria, College of Environmental Science and Engineering, Nankai University, Tianjin 300350, China
d.
Department of Natural Medicinal Chemistry, School of Pharmacy, Naval Medical University, Shanghai 200433, China

li.wang@cityu.edu.hk

zwcai@hkbu.edu.hk

Received Date: 27 September 2024
Revised Date: 6 January 2025
Accepted Date: 3 February 2025
Available Online: 5 February 2025

Figures(4)

Type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency. PPARδ activation has been reported to have several beneficial effects in alleviating dyslipidemia and insulin resistance. GW501516, a synthetic PPARδ agonist, was developed to target hyperlipidemia and reported to alleviating insulin resistance in T2DM. Studies indicate that PPARδ activation by GW501516 can reduce adiposity, enhance β-oxidation of fatty acids, and improve insulin sensitivity in T2DM animal models. Despite its therapeutic promise, potential carcinogenic effects also have been reported. Therefore, a comprehensive non-targeted and targeted lipidomics study was carried out to evaluate the regulatory effect of GW501516 in the plasma of db/db mice. The results revealed that GW501516 is effective in reducing the accumulation of lipids in the fatty acid metabolism pathway and lipid classes including triglycerides and phosphatidylglycerols. Furthermore, activation of PPARδ by GW501516 demonstrated a beneficial effect on improving circulating cholesterol homeostasis. However, while the levels of hexosylceramides and sphingomyelin were partially reversed, ceramide levels, which are negatively associated with insulin sensitivity, were significantly elevated by GW501516. Despite these mixed outcomes, the study highlights both the promising therapeutic potential of PPARδ activation in metabolic disorders and the safety concerns regarding long-term clinical use. The findings provide valuable insights into the impact of GW501516-induced PPARδ activation on lipid metabolism in T2DM, contributing to a better understanding of its therapeutic potential and risks.
- PPARδ,
- T2DM,
- GW501516,
- Lipidomics,
- db/db,
- Cholesterol
1. [1]
  R.J. Henning, Future Cardiol. 14 (2018) 491–509. doi: 10.2217/fca-2018-0045
2. [2]
  S. Tangvarasittichai, World J. Diabetes 6 (2015) 456.
3. [3]
  M.C. Petersen, G.I. Shulman, Trends Pharmacol. Sci. 38 (2017) 649–665. doi: 10.1016/j.tips.2017.04.004
4. [4]
  T. Tanaka, J. Yamamoto, S. Iwasaki, et al., Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15924–15929. doi: 10.1073/pnas.0306981100
5. [5]
  W. Fan, W. Waizenegger, C.S. Lin, et al., Cell Metab. 25 (2017) 1186–1193 e4. doi: 10.1016/j.cmet.2017.04.006
6. [6]
  X.Y. Tian, W.T. Wong, N. Wang, et al., Diabetes 61 (2012) 3285–3293. doi: 10.2337/db12-0117
7. [7]
  V.A. Narkar, M. Downes, R.T. Yu, et al., Cell 134 (2008) 405–415. doi: 10.1016/j.cell.2008.06.051
8. [8]
  S.A. Ham, H.J. Kim, H.J. Kim, et al., Cell. Mol. Med. 14 (2010) 1747–1759. doi: 10.1111/j.1582-4934.2009.00816.x
9. [9]
  L. Xiang, L. Wang, Y. Xia, et al., Innov. Life 2 (2024) 100065. doi: 10.59717/j.xinn-life.2024.100065
10. [10]
  L. Xiang, J. Nie, L. Wang, et al., Chin. Chem. Lett. 32 (2021) 2197–2202. doi: 10.1016/j.cclet.2020.12.042
11. [11]
  W.R. Oliver, J.L. Shenk, M.R. Snaith, et al., Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5306–5311. doi: 10.1073/pnas.091021198
12. [12]
  D.C. Magliano, A. Penna-de-Carvalho, M. Vazquez-Carrera, C.A. Mandarim-de-Lacerda, M.B. Aguila, Endocrine 50 (2015) 355–367. doi: 10.1007/s12020-015-0590-1
13. [13]
  W. Chen, R. Gao, X. Xie, et al., Sci. Rep. 5 (2015) 1–13.
14. [14]
  C. Zizola, P.J. Kennel, H. Akashi, et al., Am. J. Physiol. Circ. Physiol. 308 (2015) H1078–H1085. doi: 10.1152/ajpheart.00679.2014
15. [15]
  D. Zhou, J. Jin, Q. Liu, J. Shi, Y. Hou, Eur. J. Pharmacol. 842 (2019) 248–254. doi: 10.1016/j.ejphar.2018.10.050
16. [16]
  J. Qiu, T. Li, Z.J. Zhu, Anal. Chim. Acta 1142 (2021) 108–117. doi: 10.1016/j.aca.2020.10.058
17. [17]
  J. Wei, X. Li, L. Xiang, et al., J. Hazard. Mater. 390 (2020) 121451. doi: 10.1016/j.jhazmat.2019.121451
18. [18]
  Z. Pang, J. Chong, G. Zhou, et al., Nucleic Acids Res. 49 (2021) W388–W396. doi: 10.1093/nar/gkab382
19. [19]
  F. Lyu, F. Han, C. Ge, et al., iMeta 2 (2023) e85. doi: 10.1002/imt2.85
20. [20]
  S. Luquet, C. Gaudel, D. Holst, et al., Biochim. Biophys. Acta Mol. Basis Dis. 1740 (2005) 313–317. doi: 10.1016/j.bbadis.2004.11.011
21. [21]
  L. Salvadó, L. Serrano-Marco, E. Barroso, X. Palomer, M. Vázquez-Carrera, Expert Opin. Ther. Targets 16 (2012) 209–223. doi: 10.1517/14728222.2012.658370
22. [22]
  U. Dressel, T.L. Allen, J.B. Pippal, et al., Mol. Endocrinol. 17 (2003) 2477–2493. doi: 10.1210/me.2003-0151
23. [23]
  R.L. Stephen, M.C.U. Gustafsson, M. Jarvis, et al., Cancer Res. 64 (2004) 3162–3170. doi: 10.1158/0008-5472.CAN-03-2760
24. [24]
  A.I.S. Sobczak, C.A. Blindauer, A.J. Stewart, Nutrients 11 (2019) 2022. doi: 10.3390/nu11092022
25. [25]
  G. Boden, Curr. Diab. Rep. 6 (2006) 177–181. doi: 10.1007/s11892-006-0031-x
26. [26]
  P.J. Meikle, G. Wong, C.K. Barlow, et al., PLoS One 8 (2013) e74341. doi: 10.1371/journal.pone.0074341
27. [27]
  M. Schlame, L. Horvàth, L. Vìgh, Biochem. J. 265 (1990) 79–85. doi: 10.1042/bj2650079
28. [28]
  E. Sedlák, T. Kožár, A. Musatov, Cells 9 (2020) 2588. doi: 10.3390/cells9122588
29. [29]
  F. Gonzalvez, E. Gottlieb, Apoptosis 12 (2007) 877–885. doi: 10.1007/s10495-007-0718-8
30. [30]
  H.N. Ginsberg, Y.L. Zhang, A. Hernandez-Ono, Arch. Med. Res. 36 (2005) 232–240. doi: 10.1016/j.arcmed.2005.01.005
31. [31]
  X. Ye, W. Kong, M.I. Zafar, L.L. Chen, Cardiovasc. Diabetol. 18 (2019) 48. doi: 10.1007/978-3-030-27535-8_5
32. [32]
  P.L. Yeagle, Biochim. Biophys. Acta - Rev. Biomembr. 822 (1985) 267–287. doi: 10.1016/0304-4157(85)90011-5
33. [33]
  C.K. Glass, J.L. Witztum, Cell 104 (2001) 503–516. doi: 10.1016/S0092-8674(01)00238-0
34. [34]
  W. Lu, H.E. Resnick, K.A. Jablonski, et al., Diabetes Care 26 (2003) 16–23. doi: 10.2337/diacare.26.1.16
35. [35]
  C. Park, Y. Zhang, X. Zhang, J, et al., Kidney Int. 69 (2006) 1511–1517. doi: 10.1038/sj.ki.5000209
36. [36]
  D.J. Rader, G.K. Hovingh, Lancet 384 (2014) 618–625. doi: 10.1016/S0140-6736(14)61217-4
37. [37]
  J.D. Horton, J.L. Goldstein, M.S. Brown, J. Clin. Invest. 109 (2002) 1125–1131. doi: 10.1172/JCI0215593
38. [38]
  S. Galadari, A. Rahman, S. Pallichankandy, A. Galadari, F. Thayyullathil, Lipids Health Dis. 12 (2013) 98. doi: 10.1186/1476-511X-12-98
39. [39]
  J.A. Chavez, M.M. Siddique, S.T. Wang, et al., J. Biol. Chem. 289 (2014) 723–734. doi: 10.1074/jbc.M113.522847
40. [40]
  P. Düsing, N.N. Heinrich, B. Al-Kassou, et al., BMC Cardiovasc. Disord. 23 (2023) 454. doi: 10.1186/s12872-023-03454-x
41. [41]
  J. Luo, Q. Wan, S. Chen, Chin. Chem. Lett. 36 (2025) 109836. doi: 10.1016/j.cclet.2024.109836
42. [42]
  Q. Wan, Y. Xiao, G. Feng, et al., Chin. Chem. Lett. 35 (2024) 108775. doi: 10.1016/j.cclet.2023.108775
43. [43]
  G. Feng, M. Gao, H. Chen, et al., Anal. Chem. 96 (2024) 2524–2533. doi: 10.1021/acs.analchem.3c04824
1. [1]
  Xiaoxiao Wang , Bolun Wang , Fenfen Ji , Jie Yan , Jiacheng Fang , Doudou Zhang , Ji Xu , Jing Ji , Xinran Hao , Hemi Luan , Yanjun Hong , Shulan Qiu , Min Li , Zhu Yang , Wenlan Liu , Xiaodong Cai , Zongwei Cai . Discovery of plasma biomarkers for Parkinson’s disease diagnoses based on metabolomics and lipidomics. Chinese Chemical Letters, 2024, 35(11): 109653-. doi: 10.1016/j.cclet.2024.109653
2. [2]
  Fangbing Wang , Qiankun Zeng , Jing Ren , Min Zhang , Guoyue Shi . A membrane-based plasma separator coupled with ratiometric fluorescent sensor for biochemical analysis in whole blood. Chinese Chemical Letters, 2025, 36(7): 110494-. doi: 10.1016/j.cclet.2024.110494
3. [3]
  Junmeng Luo , Qiongqiong Wan , Suming Chen . Chemistry-driven mass spectrometry for structural lipidomics at the C=C bond isomer level. Chinese Chemical Letters, 2025, 36(1): 109836-. doi: 10.1016/j.cclet.2024.109836
4. [4]
  Doudou Liu , Weiwei Guo , Guoliang Mei , Youpeng Dan , Rong Yang , Chao Huang , Yanling Zhai , Xiaoquan Lu . Application of catalyst Cu-t-ZrO₂ based on the electronic metal-support interaction in electrocatalytic nitrate reduction. Chinese Chemical Letters, 2025, 36(8): 110578-. doi: 10.1016/j.cclet.2024.110578
5. [5]
  Yang Liu , Jing Liang , Mengzhu Zheng , Haoze Song , Lixia Chen , Hua Li . PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity. Chinese Chemical Letters, 2025, 36(6): 110317-. doi: 10.1016/j.cclet.2024.110317
6. [6]
  Pengyang FAN , Shan FAN , Qinjin DAI , Xiaoying ZHENG , Wei DONG , Mengxue WANG , Xiaoxiao HUANG , Yong ZHANG . Preparation and performance of rich 1T-MoS₂ nanosheets for high-performance aqueous zinc ion battery cathode materials. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 675-682. doi: 10.11862/CJIC.20240339
7. [7]
  Zhihan Chang , Yuchen Zhang , Yuan Tian , Xiuli Wang . Achieving high-proportioned 1T-MoS₂ within heterostructures derived from polymolybdate-based complex for boosting electrocatalytic hydrogen evolution and oxygen evolution. Chinese Chemical Letters, 2025, 36(8): 110197-. doi: 10.1016/j.cclet.2024.110197
8. [8]
  Kai Zhou , Ao Sun , Yuchao Wang , Hang Dong , Chenkai Bai , Yidian Mo , Xuyang Ding , Xiangbao Meng , Zhongtang Li , Zhongjun Li . Semisynthesis of rare chondroitin sulfate B and T oligosaccharides. Chinese Chemical Letters, 2025, 36(9): 110783-. doi: 10.1016/j.cclet.2024.110783
9. [9]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
10. [10]
  Yi Li , Zhaoxiang Cao , Peng Liu , Xia Wu , Dongju Zhang . Revealing the Coloration and Color Change Mechanisms of the Eriochrome Black T Indicator through Computational Chemistry and UV-Visible Absorption Spectroscopy. University Chemistry, 2025, 40(3): 132-139. doi: 10.12461/PKU.DXHX202405154
11. [11]
  Haojie Duan , Hejingying Niu , Lina Gan , Xiaodi Duan , Shuo Shi , Li Li . Reinterpret the heterogeneous reaction of α-Fe₂O₃ and NO₂ with 2D-COS: The role of SDS, UV and SO₂. Chinese Chemical Letters, 2024, 35(6): 109038-. doi: 10.1016/j.cclet.2023.109038
12. [12]
  Renshu Huang , Jinli Chen , Xingfa Chen , Tianqi Yu , Huyi Yu , Kaien Li , Bin Li , Shibin Yin . Synergized oxygen vacancies with Mn2O3@CeO2 heterojunction as high current density catalysts for Li–O2 batteries. Chinese Journal of Structural Chemistry, 2023, 42(11): 100171-100171. doi: 10.1016/j.cjsc.2023.100171
13. [13]
  Shengwen Guan , Zhaotong Wei , Ningxu Han , Yude Wei , Bin Xu , Ming Wang , Junjuan Shi . Construction of metallo-complexes with 2,2′:6′,2″-terpyridine substituted triphenylamine in different modified positions and their photophysical properties. Chinese Chemical Letters, 2024, 35(7): 109348-. doi: 10.1016/j.cclet.2023.109348
14. [14]
  Maomao Liu , Guizeng Liang , Ningce Zhang , Tao Li , Lipeng Diao , Ping Lu , Xiaoliang Zhao , Daohao Li , Dongjiang Yang . Electron-rich Ni2+ in Ni3S2 boosting electrocatalytic CO2 reduction to formate and syngas. Chinese Journal of Structural Chemistry, 2024, 43(8): 100359-100359. doi: 10.1016/j.cjsc.2024.100359
15. [15]
  Yongheng Ren , Yang Chen , Hongwei Chen , Lu Zhang , Jiangfeng Yang , Qi Shi , Lin-Bing Sun , Jinping Li , Libo Li . Electrostatically driven kinetic Inverse CO2/C2H2 separation in LTA-type zeolites. Chinese Journal of Structural Chemistry, 2024, 43(10): 100394-100394. doi: 10.1016/j.cjsc.2024.100394
16. [16]
  Huirong Chen , Yingzhi He , Yan Han , Jianbo Hu , Jiantang Li , Yunjia Jiang , Basem Keshta , Lingyao Wang , Yuanbin Zhang . A new SIFSIX anion pillared cage MOF with crs topological structure for efficient C2H2/CO2 separation. Chinese Journal of Structural Chemistry, 2025, 44(2): 100508-100508. doi: 10.1016/j.cjsc.2024.100508
17. [17]
  Cailiang Yue , Nan Sun , Yixing Qiu , Linlin Zhu , Zhiling Du , Fuqiang Liu . A direct Z-scheme 0D α-Fe₂O₃/TiO₂ heterojunction for enhanced photo-Fenton activity with low H₂O₂ consumption. Chinese Chemical Letters, 2024, 35(12): 109698-. doi: 10.1016/j.cclet.2024.109698
18. [18]
  Liyong Ding , Zhenhua Pan , Qian Wang . 2D photocatalysts for hydrogen peroxide synthesis. Chinese Chemical Letters, 2024, 35(12): 110125-. doi: 10.1016/j.cclet.2024.110125
19. [19]
  Wenlong LI , Xinyu JIA , Jie LING , Mengdan MA , Anning ZHOU . Photothermal catalytic CO₂ hydrogenation over a Mg-doped In₂O_3-x catalyst. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 919-929. doi: 10.11862/CJIC.20230421
20. [20]
  Xiangyuan Zhao , Jinjin Wang , Jinzhao Kang , Xiaomei Wang , Hong Yu , Cheng-Feng Du . Ni nanoparticles anchoring on vacuum treated Mo2TiC2Tx MXene for enhanced hydrogen evolution activity. Chinese Journal of Structural Chemistry, 2023, 42(10): 100159-100159. doi: 10.1016/j.cjsc.2023.100159

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(22)
HTML views(4)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142